Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07472088 · ClinicalTrials.gov registry record

Assessing the Association Between WBCT PFJ Morphological Metrics and Knee Symptoms

A clinical trial, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
36
Enrollment target

NCT07472088: Recruiting study, sponsored by University of Kansas Medical Center.

NCT07472088 is a clinical trial that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07472088 is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
36 participants
Enrollment target

Study Summary

Patellofemoral joint (PFJ) pain is a common, often chronic, aching pain behind or around the kneecap, frequently called "runner's knee". It occurs when the kneecap does not glide smoothly over the thigh bone, often due to muscle weakness or overuse. It makes sitting for long periods, climbing stairs, or kneeling painful. Symptomatic knee osteoarthritis (OA) is a common, long-term condition where the protective cartilage in the knee joint wears away, causing the bones to rub together, leading to daily pain and stiffness. In simple terms, it is a "wear-and-tear" disease of the entire joint that makes walking, climbing stairs, or bending the knee difficult. The PFJ is where the patella (kneecap) meets the femoral trochlea (front part of the lower thigh bone) at the front of the knee. Patellar tracking refers to the movement of the patella that begins to engage in the distal femoral trochlear groove (smooth, U-shaped groove at the bottom of the thigh bone). By doing this study, we hope to advance clinical knowledge of the PTJ features in a more natural position by using weight-bearing computed tomography (WBCT) images while the leg is straight and slightly bent. Determining links between specific knee symptoms and the PTJ structure on WBCT images could enable providers to effectively target the underlying causes and to develop targeted treatments.

Primary Outcome

Tibial Tuberosity - Trochlear Grove (TT-TG) will be measured on 3D WBCT knee images acquired at 0° and 20±5° of knee flexion.

Interventions

  • RADIATION WBCT

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2026-04-29
Est. Completion 2026-08
University of Kansas Medical Center

408 total trials

What NCT07472088 shows while recruiting

NCT07472088 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which WBCT is the first listed.

NCT07472088 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07472088 about?

NCT07472088 is a clinical study titled "Assessing the Association Between WBCT PFJ Morphological Metrics and Knee Symptoms". Patellofemoral joint (PFJ) pain is a common, often chronic, aching pain behind or around the kneecap, frequently called "runner's knee". It occurs when the kneecap does not glide smoothly over the thigh bone, often due to muscle weakness or overuse. It makes sitting for long periods, climbing stairs...

What is the current status of trial NCT07472088?

This trial is currently recruiting. The enrollment target is 36 participants. The study started on 2026-04-29. Estimated completion is 2026-08.

What interventions are being tested in trial NCT07472088?

The interventions under investigation include: WBCT (RADIATION).

Who is sponsoring clinical trial NCT07472088?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07472088, the US trial registry maintained by the National Library of Medicine. NCT07472088 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.